Edition:
India

Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

150.28USD
19 Jul 2018
Change (% chg)

$0.47 (+0.31%)
Prev Close
$149.81
Open
$149.76
Day's High
$151.53
Day's Low
$149.76
Volume
155,441
Avg. Vol
332,573
52-wk High
$155.16
52-wk Low
$100.20

Latest Key Developments (Source: Significant Developments)

Edwards Lifesciences Says Entered Into Credit Agreement To Establish Multi-Currency Unsecured Revolving Credit Facility - SEC Filing
Tuesday, 1 May 2018 

April 30 (Reuters) - Edwards Lifesciences Corp ::EDWARDS LIFESCIENCES SAYS ENTERED INTO CREDIT AGREEMENT TO ESTABLISH NEW 5-YEAR $750 MILLION MULTI-CURRENCY UNSECURED REVOLVING CREDIT FACILITY - SEC FILING.EDWARDS LIFESCIENCES SAYS NEW AGREEMENT TO REPLACE THE EXISTING $750 MILLION UNSECURED REVOLVING CREDIT FACILITY UNDER THE 2014 CREDIT AGREEMENT.EDWARDS LIFESCIENCES - MAY INCREASE AMOUNT OF REVOLVING CREDIT FACILITY UNDER CREDIT AGREEMENT BY UP TO ADDITIONAL $250 MILLION IN THE AGGREGATE.  Full Article

Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences
Tuesday, 17 Apr 2018 

April 16 (Reuters) - Boston Scientific Corp ::BOSTON SCIENTIFIC PREVAILS IN EUROPEAN PATENT DISPUTE WITH EDWARDS LIFESCIENCES.BOSTON SCIENTIFIC CORP - SUCCESSFULLY OPPOSED EDWARDS LIFESCIENCES' EUROPEAN PATENT EP 2,399,550, RESULTING IN REVOCATION OF PATENT.BOSTON SCIENTIFIC - GERMAN COURT OF APPEAL TO HAVE HEARING IN MAY, JUNE THIS YEAR ABOUT CO'S PATENTS '254, '766 THAT EDWARDS WAS FOUND TO INFRINGE.  Full Article

Edwards Lifesciences Corp Says CEO Michael Mussallem's FY 2017 Total Compensation Was $10.8 Mln Vs $9.7 Mln In FY 2016
Friday, 30 Mar 2018 

March 29 (Reuters) - Edwards Lifesciences Corp ::EDWARDS LIFESCIENCES CORP SAYS CEO MICHAEL MUSSALLEM'S FY 2017 TOTAL COMPENSATION WAS $10.8 MILLION VERSUS $9.7 MILLION IN FY 2016 - SEC FILING.  Full Article

Edwards Lifesciences Corp Acquires Harpoon Medical
Thursday, 7 Dec 2017 

Dec 6 (Reuters) - Edwards Lifesciences Corp ::EDWARDS ACQUIRES HARPOON MEDICAL.EDWARDS LIFESCIENCES CORP - EDWARDS PAID $100 MILLION IN CASH FOR HARPOON AT CLOSING ON DEC. 1.EDWARDS LIFESCIENCES - THERE IS POTENTIAL FOR UP TO $150 MILLION IN MILESTONE PAYMENTS OVER NEXT 10 YEARS AS PART OF DEAL.EDWARDS LIFESCIENCES - JAMES GAMMIE HAD AN EQUITY INTEREST IN HARPOON MEDICAL, AND WILL SERVE AS A CONSULTANT TO EDWARDS LIFESCIENCES.  Full Article

Edwards Lifesciences reports quarterly share of $0.79
Wednesday, 25 Oct 2017 

Oct 24 (Reuters) - Edwards Lifesciences Corp ::Edwards Lifesciences - Qtrly earnings per share $0.79; Qtrly adjusted earnings per share $0.84; Qtrly sales $821.5 million, up 11.1 percent.Edwards Lifesciences - Qtrly Transcatheter Heart Valve Therapy sales of $481.2 million, up 17.3 percent.Q3 earnings per share view $0.86, revenue view $832.0 million -- Thomson Reuters I/B/E/S.Edwards lifesciences - Reaffirmed FY sales estimate at high end of $3.2 to $3.4 billion range, FY adjusted EPS estimate of $3.65 to $3.85.Edwards lifesciences - "Experienced minimal business impact" from recent natural disasters.FY2017 earnings per share view $3.78, revenue view $3.39 billion -- Thomson Reuters I/B/E/S.  Full Article

FDA approves expanded indication for Sapien XT and Sapien 3 transcatheter heart valves
Friday, 19 Aug 2016 

U.S. FDA : U.S. Food and Drug Administration today approved an expanded indication for the Sapien XT and Sapien 3 transcatheter heart valves .Requiring Edwards to conduct post-approval study to follow patients treated with either device in first,second clinical studies for 10 years.  Full Article

EDWARDS INTUITY Elite Rapid Deployment Valve receives FDA approval
Monday, 15 Aug 2016 

Edwards Lifesciences Corp :Edwards INTUITY Elite Rapid Deployment Valve receives FDA approval.  Full Article